NCT06815107 Risk Factors for Poor Tolerance of Ureteral Double-J Stent
| NCT ID | NCT06815107 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | Tolerance |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-04-15 |
| Primary Completion | 2021-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2020-04-15 with a primary completion date of 2021-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong socio-economic impact. The objective of this study is the identification of the predictive factors of poor tolerance.
Eligibility Criteria
Inclusion Criteria: * patient over 18 years old * patient who need Ureteral Double-J Stenting Exclusion Criteria: * patient under 18 years old, * Iterative change, * understanding disorder, * inability to answer the questionnaire, * refusal of the patient, * long-term Ureteral Double-J Stenting (more than 6 month), * active cancer.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06815107 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tolerance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06815107 currently recruiting?
Yes, NCT06815107 is actively recruiting participants. Contact the research team at desousa.philippe@chu-amiens.fr for enrollment information.
Where is the NCT06815107 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT06815107 clinical trial?
NCT06815107 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 200 participants.